{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:42:40Z","timestamp":1792190560574,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00848"],"award-info":[{"award-number":["PI14\/00848"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00324"],"award-info":[{"award-number":["PI17\/00324"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jaut.2019.05.013","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T22:15:30Z","timestamp":1559945730000},"page":"102285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity"],"prefix":"10.1016","volume":"103","author":[{"given":"Daniel","family":"\u00c1lvarez-Sierra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mar\u00edn-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Ruiz-Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"de Jes\u00fas Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Iglesias-Felip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Casteras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser Ferrer","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Nuciforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Colobran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pujol-Borrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.05.013_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.jaut.2019.05.013_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2009.11.019","article-title":"The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution","volume":"34","author":"Hemminki","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.05.013_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","article-title":"The etiology of autoimmune thyroid disease: a story of genes and environment","volume":"32","author":"Tomer","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.05.013_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1055\/a-0755-7927","article-title":"Central tolerance mechanisms to TSHR in graves' disease: contributions to understand the genetic association","volume":"50","author":"Pujol-Borrell","year":"2018","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.jaut.2019.05.013_bib5","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1073\/pnas.93.6.2260","article-title":"Checkpoints in the progression of autoimmune disease: lessons from diabetes models","volume":"93","author":"Andr\u00e9","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.05.013_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2019.05.013_bib7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0002-9440(10)61762-2","article-title":"Thyroid autoimmune disease:demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine- containing active intrathyroidal germinal centers","volume":"159","author":"Armengol","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2019.05.013_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(83)90628-1","article-title":"Aberrant expression of HLA-DR antigen on thyrocytes in graves' disease: relevance for autoimmunity","volume":"322","author":"Hanafusa","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2019.05.013_bib9","article-title":"Hyperexpression of transporter in antigen processing-1 (TAP-1) in thyroid glands affected by autoimmunity: a contributory factor to the breach of tolerance to thyroid antigens?","author":"Sospedra","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0896-8411(05)80056-3","article-title":"Induction of intercellular adhesion molecule-1 but not of lymphocyte function-associated antigen-3 in thyroid follicular cells","volume":"5","author":"Tolosa","year":"1992","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.05.013_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2011.01.002","article-title":"Analysis of the cumulative changes in Graves' disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors","volume":"36","author":"Ruiz-Riol","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.05.013_bib12","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.05.013_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","author":"Keir","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.05.013_bib15","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4049\/jimmunol.1701231","article-title":"Dendritic cell PD-L1 limits autoimmunity and follicular T cell differentiation and function","volume":"200","author":"Sage","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib16","article-title":"PD-1 immunobiology in systemic lupus erythematosus","author":"Curran","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.05.013_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory pathways in immunotherapy for cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib18","doi-asserted-by":"crossref","first-page":"11823","DOI":"10.1073\/pnas.0505497102","article-title":"Establishment of NOD-Pdcd1-\/- mice as an efficient animal model of type I diabetes","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jaut.2019.05.013_bib19","doi-asserted-by":"crossref","DOI":"10.2337\/db07-1260","article-title":"Protective role of programmed death 1 ligand 1 (PD-L1) in nonobese diabetic mice: the paradox in transgenic models","author":"Wang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2019.05.013_bib20","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1038\/s41598-018-26471-9","article-title":"Interferon-gamma drives programmed death-ligand 1 expression on islet \u03b2 cells to limit T cell function during autoimmune diabetes","volume":"8","author":"Osum","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.05.013_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2019.05.013_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2265.2007.02848.x","article-title":"Tag SNP screening of the PDCD1 gene for association with Graves? disease","volume":"67","author":"Simmonds","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jaut.2019.05.013_bib23","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1210\/jc.2009-1404","article-title":"Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and graves' disease susceptibility","volume":"94","author":"Mitchell","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2019.05.013_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","article-title":"Cancer immunotherapy-immune checkpoint blockade and associated endocrinopathies","volume":"13","author":"Byun","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jaut.2019.05.013_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/er.2018-00006","article-title":"Endocrine toxicity of cancer immunotherapy targeting immune checkpoints","volume":"40","author":"Chang","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2019.05.013_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0896-8411(91)90155-6","article-title":"De novo HLA Class II and enhanced HLA Class I molecule expression in SV40 transfected human thyroid epithelial cells","volume":"4","author":"Belfiore","year":"1991","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.05.013_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2012.00133","article-title":"Thyroid cancer cell lines: an overview","volume":"3","author":"Saiselet","year":"2012","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jaut.2019.05.013_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2015.10.005","article-title":"Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells","volume":"419","author":"Jeon","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jaut.2019.05.013_bib29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jaut.2019.05.013_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, Generation, and Maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human Immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib32","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.4049\/jimmunol.170.12.6320","article-title":"Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases","volume":"170","author":"Armengol","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-66-2-367","article-title":"Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies","volume":"66","author":"Lucas-Martin","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2019.05.013_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.humimm.2006.04.013","article-title":"Immune accessory functions of human endothelial cells are modulated by overexpression of B7-H1 (PDL1)","volume":"67","author":"LaGier","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib35","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2019.05.013_bib36","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2014-1735","article-title":"MRNA-Seq reveals novel molecular mechanisms and a robust fingerprint in Graves' disease","volume":"99","author":"Yin","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2019.05.013_bib37","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.154.8.4213","article-title":"Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?","volume":"154","author":"Sospedra","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.21037\/atm.2017.09.32","article-title":"Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors","volume":"5","author":"Imamovic","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jaut.2019.05.013_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.05.013_bib40","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Freeman","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory pathways in the B7-CD28 ligand-receptor family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2019.05.013_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib43","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1172\/JCI40040","article-title":"PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice","volume":"120","author":"Mueller","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2019.05.013_bib44","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1038\/s41598-018-26471-9","article-title":"Interferon-gamma drives programmed death-ligand 1 expression on islet \u03b2 cells to limit T cell function during autoimmune diabetes","volume":"8","author":"Osum","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2019.05.013_bib45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaut.2019.05.013_bib46","first-page":"116","article-title":"Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis","volume":"37","author":"Yuan","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.jaut.2019.05.013_bib47","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.05.013_bib48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.it.2017.10.003","article-title":"Forum T FH cells play defense in cancer and offense in arthritis","volume":"38","author":"Gu-Trantien","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2019.05.013_bib49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: a novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jaut.2019.05.013_bib50","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.immuni.2012.03.024","article-title":"Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1","volume":"36","author":"Scium\u00e8","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2019.05.013_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.94.1.193","article-title":"Reexpression of blood group abh antigens on the surface of human thyroid cells in culture","volume":"94","author":"Khoury","year":"1982","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jaut.2019.05.013_bib52","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7431","article-title":"PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma","volume":"7","author":"Ock","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2019.05.013_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.04.017","article-title":"Co-stimulatory and Co-inhibitory pathways in autoimmunity","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2019.05.013_bib54","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1111\/cas.13800","article-title":"Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab","volume":"109","author":"Kimbara","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jaut.2019.05.013_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/js.2017-00432","article-title":"Patients with antithyroid antibodies are prone to develop destructive thyroiditis by nivolumab: a prospective study","volume":"2","author":"Kobayashi","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.jaut.2019.05.013_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/304071a0","article-title":"Lectin-induced expression of DR antigen on human cultured follicular thyroid cells","volume":"304","author":"Pujol-Borrell","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.05.013_bib57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coi.2016.09.005","article-title":"T cell exhaustion and immune-mediated disease \u2014 the potential for therapeutic exhaustion","volume":"43","author":"McKinney","year":"2016","journal-title":"Curr. Opin. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119301568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119301568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:28Z","timestamp":1760257408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119301568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":57,"alternative-id":["S0896841119301568"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.05.013","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the PD-1\/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102285"}}